These γδ17 T cell expansions and IL‐17 secretion can have three major consequences that benefit tumor progression: promotion of angiogenesis, stimulation of tumor cell proliferation, and orchestration of an immunosuppressive TME (Fig. 2). Here, IL17A is linked to neoplasm.